Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Alpha Medical is One of the First Telemedicine Platforms to Offer Outpatient COVID-19 Treatment

Leading telemedicine company dedicated to women's healthcare expands its platform to prescribe PAXLOVIDTM in an effort to treat COVID-19


News provided by

Alpha Medical

Jan 19, 2022, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Alpha Medical Logo
Alpha Medical Logo

PALO ALTO, Calif., Jan. 19, 2022 /PRNewswire-PRWeb/ -- Alpha Medical, a virtual primary care group that empowers women to take control of their healthcare by offering a medical team specifically trained for a woman's unique needs, announces a new product offering. Starting today, Alpha's integrated women's health platform and its team of trained providers will prescribe PAXLOVIDTM, an investigational medication used to treat mild-to-moderate COVID-19 in adults and children 12 years of age and older, and are at high risk for progression to severe COVID-19, including hospitalization or death, under a EUA.

According to Pfizer, the drug manufacturer, use of PAXLOVIDTM reduces the risk of hospitalization or death by 89 percent in trials. With the rapid transmission of the Omicron variant, cases have surged in recent weeks. Yet there is still a vast shortage of doctors and medical staff to treat, diagnose, and prescribe medication to patients. With the likelihood of PAXLOVIDTM being difficult to access, it is Alpha's hope that their proven asynchronous telehealth platform and team's dedication to making primary care accessible for women, will help. The platform will also feature a custom locator tool on the site to help point patients to their nearest pharmacy with inventory.

"As COVID-19 cases continue to spike across the United States, Alpha Medical is proud to be one of the first telehealth companies to expand its resources to help those battling this virus,” says Gloria Lau, Co-founder & CEO.

Post this

"As COVID-19 cases continue to spike across the United States, Alpha Medical is proud to be one of the first telehealth companies to expand its resources to help those battling this virus," says Gloria Lau, Co-founder & CEO. "It was critical for us to act quickly here as we fully recognize the need for women, now more than ever, to get speedy access to telemedicine visits and prescriptions. We're prepared to continue our mission of helping our patients through these unprecedented times with highly accessible medical resources."

Alpha Medical, whose services are available in 49 states plus DC and treat over 60 conditions with their virtual PCP offering, continues to fulfill its mission to bring convenient, affordable, and accessible medical care, medications, and resources to its patients. Following the FDA ruling to authorize the emergency use of PAXLOVIDTM, Alpha providers are now able to prescribe COVID-19 treatment when appropriate, to a patient's local pharmacy through their asynchronous telemedicine platform.

Also, given the supply shortage issues with PAXLOVIDTM, Alpha has built a custom tool that integrates with the country's supply database to identify nearby locations where the drug is in stock. Since Alpha offers continuity of care through dedicated providers that patients can return to with every visit, their personalized treatment plan can also take into account potential drug interactions and other pre-existing conditions that may affect their eligibility for PAXLOVIDTM.

To learn more about Alpha Medical and its initiatives, please visit https://www.helloalpha.com/.

To learn more about COVID-19, please visit https://www.cdc.gov/COVID19 or contact your local or state public health department.

ABOUT ALPHA MEDICAL
From birth control to menopause, from urgent care to chronic disease, Alpha offers a PCP-centric, whole-person care platform built for her that covers all of her virtual care needs. Each patient gets a dedicated PCP when she signs up, and the same provider cares for all of her primary medical needs online to ensure the continuation of care. All of Alpha's medical providers have been specifically trained in women's health. Our system anticipates her needs through data-driven proactive screenings, and we are built for cost-effective triage, prescription management, therapy, and referrals. The offering is available at a demonstrably lower cost than other virtual solutions on the market, helping much needed populations with high deductible plans or no insurance. We are here to rebuild the patient-provider relationship, and at the core of the offering is a dedicated PCP trained in women's health. We are here to destigmatize her needs by reshaping women's health, including reproductive, primary and urgent care, and mental health. We can bring about a more accessible, equitable system to care for everyone.

Media Contact
Kristen Mondshein
[email protected]

Media Contact

Kristen Mondshein, Alpha Medical, +1 3058773293, [email protected]

SOURCE Alpha Medical

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.